Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Funding of PRRT (Lutate) in New South Wales

Funding of PRRT (Lutate) in New South Wales

  • August 18, 2013
The Unicorn Foundation continues to advocate for greater access and funding for Peptide Receptor Radionuclide Therapy (PRRT).

In New South Wales, Dr John Leyden has been the consumer representative involved with the Agency of Clinical Innovations (ACI) Nuclear Medicine group development of 'Lutate therapy for NET patients in NSW' since 2010. The final submission was completed and submitted to the Minister for Health, Hon Jillian Skinner MP for consideration.

Dr John Leyden, on behalf of NSW NET cancer patients, met with NSW Health Senior Policy Advisor Cassandra Smith and ACI Chief Executive Dr Nigel Lyons to discuss the importance of and desperate need to fund Lutate in designated NSW public hospitals as per the proposal.

The Unicorn Foundation strongly urges all NSW NET patients, carers and friends to contact their local NSW Member of Parliament and request that they ask Health Minister Hon Jillian Skinner to fund Lutate therapy. We need this treatment and we need it now.

For more information to assist in this action, please contact Dr John Leyden at john.leyden@unicornfoundation.org.au

Share this post

Recent posts

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

June 16, 2025

2025 Impact Report

June 16, 2025

Be the Voice for NET Patients in WA – Join Our CAG Team

June 10, 2025

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
NextAdvocating for Equitable Access to TreatmentsNext

Related Posts

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NeuroEndocrine Cancer Australia (NECA) was proud to attend the 5th Neuroendocrine Tumour (NET) Preceptorship held 13 & 14th June at Peter MacCallum Cancer Centre in

2025 Impact Report

This year, NeuroEndocrine Cancer Australia continued to expand our reach and impact thanks to the incredible support of our community. Click below to read the

Be the Voice for NET Patients in WA – Join Our CAG Team

Call out for a consumer advisory representative from Western Australia (voluntary position) Are you from Western Australia? Have you experienced a diagnosis of a Neuroendocrine

WA Cancer Forum

The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA,  held its second annual one-day symposium “Cancer Network Forum

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin